Literature DB >> 28237206

Toward a Hedonic Value Framework in Health Care.

Anirban Basu1, Sean D Sullivan2.   

Abstract

In well-functioning markets, a hedonic pricing scheme can reflect the marginal valuation of various attributes of a differentiated product at market equilibrium. It serves as an important tool to inform pricing of a new product with a specific combination of attributes. Because health cannot be bought and sold in a market setting, and health care markets are distorted by insurance or government subsidies, direct valuation of a health intervention as a differentiated good through observed market prices is difficult. In this article, we discuss the rationale of using stated preference methods for developing a hedonic value framework for health insurance products to inform the decision on whether a product should be covered or subsidized by insurance, given its price. This value index will not reflect marginal value at market equilibrium, as in a hedonic pricing scheme, but would capture the distribution of marginal value in the population. We discuss how affordability concerns can be integrated into the development of a hedonic valuation model. We compare this framework with traditional cost-effectiveness analysis and also the existing value frameworks put forth by various organizations. The framework can be adopted to inform other decisions such as pricing. We argue that developing such a comprehensive and decision-theoretic value framework is feasible and, if successful, can serve to inform health care resource allocation in this country for decades to come in a systematic manner.
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Keywords:  hedonic pricing; insurance; value; value framework

Mesh:

Substances:

Year:  2017        PMID: 28237206     DOI: 10.1016/j.jval.2016.11.022

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  2 in total

1.  Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study.

Authors:  Shelby Reed; Juan Marcos Gonzalez; F Reed Johnson
Journal:  Value Health       Date:  2020-09-04       Impact factor: 5.725

2.  Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5].

Authors:  Charles E Phelps; Darius N Lakdawalla; Anirban Basu; Michael F Drummond; Adrian Towse; Patricia M Danzon
Journal:  Value Health       Date:  2018-02       Impact factor: 5.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.